Mavorixafor
X4P-001-103
Phase 3 small_molecule active
Quick answer
Mavorixafor for WHIM Syndrome is a Phase 3 program (small_molecule) at X4 Pharmaceuticals, Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- X4 Pharmaceuticals, Inc
- Indication
- WHIM Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active